
SanDisk (SNDK) saw unusually high options activity with 127,380 contracts traded (≈12.7 million underlying shares), equal to roughly 64.6% of its one‑month average daily share volume (19.7M); notable concentration at the $600 put expiring Feb 6, 2026 with 8,545 contracts (~854,500 shares). Boston Scientific (BSX) logged 79,665 contracts (≈8.0M underlying shares), about 59.3% of its one‑month average daily volume (13.4M), led by 15,626 contracts (~1.6M shares) in the $90 call expiring Apr 17, 2026. These flows reflect significant positioning and could drive intraday volatility or directional pressure in the two names as traders hedge or speculate ahead of the listed expirations.
Market structure: Large block activity in SNDK (8,545 Feb 6 2026 $600 puts ≈854.5k shares) and BSX (15,626 Apr 17 2026 $90 calls ≈1.56m shares) is material versus ADV (SNDK 64.6%, BSX 59.3%) and will likely force dealer delta-hedging flows. Immediate winners: option buyers if directional move follows hedging (BSX upside, SNDK downside); liquidity providers/prop desks who can capture gamma; competitors in memory (for SNDK) and medtech (for BSX) see short-term pricing volatility. Losers: short-tenor holders caught on wrong side of dealer flows and any levered funds in these names. Risk assessment: Short-term (days–weeks) the dominant tail risk is flow-driven liquidity squeezes or reversals as dealers rebalance—price swings of ±5–15% are plausible intraday if block hedging persists. Medium-term (months to expiry) key catalysts include company-specific news (FDA decisions for BSX, product/capacity updates for SNDK), NAND memory price cycles, and macro risk that could invert these directional bets. Hidden dependency: large block options may be part of complex spreads or corporate-event hedges (M&A or buyback), so treat single-strike flows as noisy signals until open interest and trade prints confirm continuation. Trade implications: Expect short-term buying pressure into BSX as dealers hedge calls and selling pressure on SNDK as they hedge puts; this creates a clear directional trade window that decays as IV/gamma cools approaching expiries (Feb 6 and Apr 17, 2026). Volatility plays: buy BSX Apr 17 2026 $90 calls for asymmetric upside capture, and buy SNDK Feb 6 2026 $600 puts as protection/speculation—both sized modestly (1–2% notional) and timed to expiries. If implied vol spikes >30% above 30‑day historical vol, pivot to spread structures (verticals) to limit theta risk. Contrarian angles: The market may be over-attributing directional intent to these prints—if follow-on open interest fails to rise +50% in 3 trading days the block was likely a hedge, not a pure directional bet, and a short-cover pop could occur. Historical parallel: dealer gamma episodes (e.g., concentrated single‑strike flows) often reverse once liquidity providers neutralize positions; therefore trim exposure after 8–12% move and watch IV/skew; unintended consequence is that aggressive market-maker hedging can exacerbate moves and then trigger fast mean-reversion when positions are unwound.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment